LiveOne, Inc. - Common Stock LVO 深 沪
等待开盘 11-04 09:30:00 美东时间
5.19
-0.410
-7.32%
华盛通- 最 高5.747
- 今 开5.55
- 成交量 13.08万股
- 最 低 5.16
- 昨 收 5.60
- 总市值 5989.93万
- 52周最高 16.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.92
- 委 比 98.49%
- 总股本 1154.13万
- 历史最高 109.0524
- 量 比 1.27
- 振 幅 10.48%
- 历史最低 2.7824
- 每 手 1
- 风险率 2.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多LiveOne's Partners with Intuizi For The Launch Of Slacker; Tesla Ad-Supported Subscribers Have Grown To 1M+ Over The Last Year; 60% ARPU Increase To Over $5; 31%+ Increase In Subscription Engagement Since Launch; 22%+ Increase In Plus/premium Conversions Since Launch
Tesla ad-supported subscribers have grown to 1M+ over the last year60% ARPU increase to over $531%+ increase in subscription engagement since launch22%+ increase in Plus/Premium conversions since launchLOS ANGELES, Nov.
11-03 21:40
12 Communication Services Stocks Moving In Thursday's After-Market Session
Gainers EPWK Holdings (NASDAQ:EPWK) stock moved upwards by 7.2% to $0.07 during...
10-31 05:07
LiveOne (Nasdaq: LVO) to Launch Subsidiary LiveOneAfrica in Partnership with Virtuosity Music Group
LiveOne announced its partnership with Virtuosity Music Group to launch LiveOneAfrica, targeting the fast-growing African music and entertainment market with over 100 million subscribers and $500 million in revenue. UK Structured Finance Ltd is engaged to raise $20 million to support LiveOne’s strategic initiatives in Europe and Africa, including digital infrastructure development, artist partnerships, and localized content creation. The partners...
10-20 11:00
LiveOne (Nasdaq: LVO) Regains Compliance with Nasdaq Listing Requirements
LiveOne's stock has regained compliance with Nasdaq Listing Rule 5550(a)(2), reflecting the company's financial and operational stability. With $5.5M remaining in its buyback program, LiveOne is well-positioned to attract institutional investors and enhance market liquidity.
10-14 13:46
LiveOne (NASDAQ: LVO) Partners With METAvivor to Fund Metastatic Breast Cancer Research, Live Streaming #LightUpMBC Live on October 13, 2025
LiveOne to Stream #LightUpMBC Live on Oct 13 to Support Metastatic Breast Cancer Research. Global event features 270 landmarks lighting up in teal, green, and pink across U.S. and worldwide. Stream will include performances by Broadway stars, Grammy winner Bootsy Collins, and pop artists Em Beihold and e.woolf. Event benefits METAvivor Research and Support Inc., funding vital research for a cure. Virtual attendees can join at liveone.com/LightUpM...
10-09 12:00
LiveOne (Nasdaq: LVO) to Stream BKFC Ice Wars 3: Bare Knuckle Brawls LIVE from Amerant Bank Arena to Fans in Over 200 Countries
LiveOne has announced its partnership with BKFC Ice Wars to stream "BKFC Ice Wars 3: Bare Knuckle Brawls" live from Amerant Bank Arena in Florida on October 10, 2025. This event marks the first BKFC Ice Wars in Florida and the first legally sanctioned bare-knuckle fights on real ice globally. The card includes a heavyweight showdown between Nick Laporte and Sébastien Lafferière, a match between Charles "Boston Strong" Rosa and Reid "The Spaz" Kra...
10-02 12:00
LiveOne Appeals Nasdaq Delisting with Reverse Stock Split
LiveOne ( ($LVO) ) has issued an announcement. LiveOne, Inc. is facing potentia...
10-02 05:50
LiveOne Completes $10M Financing, Reduces Headcount To 95, Retires $14M Short-Term Liabilities, Repurchases $6.5M Stock, Acquires 347K Shares Of PodcastOne
LiveOne (Nasdaq: LVO), an award-winning, creator-first, music, entertainment, and technology platform, released today the following letter to stockholders from its CEO and Chairman Robert Ellin.The full text of the
10-01 19:55
LiveOne (Nasdaq: LVO) Issues Stockholder Letter
LiveOne CEO Robert Ellin在致股东信中概述了公司近期取得的关键成就，包括完成4500万美元重组计划、优化运营、增强财务状况及推进加密资产战略。公司已完成1000万美元股票融资，员工精简至95人，并回购650万美元股票。比特币 treasury布局500万美元，并获5亿美元扩展授权。 PodcastOne收入增长19%，EBITDA激增348%。 LiveOne看好未来，拟扩大现场活动、推进Slacker上市或合并计划，同时认为股票被低估，管理层承诺增持300万美元，彰显信心。
10-01 11:45
Cytokinetics Presents Additional Data Related To Aficamten In Late Breaking Clinical Research Session At HFSA Annual Scientific Meeting 2025
Additional Data from MAPLE-HCM Show Aficamten Significantly Improves Measures of Maximaland Submaximal Exercise Capacity and Recovery Compared to Metoprolol96-Week Analyses from FOREST-HCM SupportLong-Term Efficacy and Tolerability of Aficamten in Patients with Non-Obstructive HCM
09-29 19:36
